These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3129838)

  • 21. Experimental studies on the immunosuppressive action of cyclosporine.
    Matsuura T; Uemura T; Kunikata S; Kanda H; Akiyama T; Kurita T
    Dev Toxicol Environ Sci; 1986; 14():149-52. PubMed ID: 2951243
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporin receptors on human lymphocytes.
    Ryffel B; Götz U; Heuberger B
    J Immunol; 1982 Nov; 129(5):1978-82. PubMed ID: 6981669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of the beta-subunit of the IL-2 receptor induces MHC-unrestricted cytotoxicity in T acute lymphoblastic leukemia cells and normal thymocytes.
    Colamonici OR; Rosolen A; Cole D; Kirsch I; Felix C; Poplack DG; Neckers LM
    J Immunol; 1988 Aug; 141(4):1202-5. PubMed ID: 3135323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
    Rubin LA; Kurman CC; Fritz ME; Biddison WE; Boutin B; Yarchoan R; Nelson DL
    J Immunol; 1985 Nov; 135(5):3172-7. PubMed ID: 3930598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cyclosporine on nuclear function.
    Citterio F; Kahan BD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):75-9. PubMed ID: 3363668
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
    Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of dialysis patients' lymphocyte IL-2R expression by glucocorticoids and cyclosporine.
    Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Samaniego MD; Choi MJ; Burdick JF
    Cytokine; 1997 Aug; 9(8):624-8. PubMed ID: 9245491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes.
    Heeg K; Gillis S; Wagner H
    J Immunol; 1988 Oct; 141(7):2330-4. PubMed ID: 3262657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
    Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of interleukin 2 to target cells: determination of high and low affinity binding sites on T-lymphoblasts by differential dissociation.
    Horst HJ; Flad HD
    Clin Exp Immunol; 1985 Dec; 62(3):579-85. PubMed ID: 3936657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.
    Pelosi-Testa E; Samoggia P; Giannella G; Montesoro E; Caravita T; Salvo G; Camagna A; Isacchi G; Testa U; Peschle C
    Immunology; 1988 Jun; 64(2):273-9. PubMed ID: 3134296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.
    Chae DW; Nosaka Y; Strom TB; Maslinski W
    J Immunol; 1996 Oct; 157(7):2813-9. PubMed ID: 8816384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
    Taniguchi N; Miyawaki T; Yachie A
    Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones.
    Andrew ME; Braciale VL; Braciale TJ
    J Immunol; 1984 Feb; 132(2):839-44. PubMed ID: 6418812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulatory effect of thyrotropin (TSH) on interleukin-2 (IL-2) release from human peripheral blood lymphocytes. A dose-response study in vitro.
    Komorowski J; Zylińska K; Pawlikowski M; Stepień H
    Horm Metab Res; 1993 Nov; 25(11):598-9. PubMed ID: 8288166
    [No Abstract]   [Full Text] [Related]  

  • 36. Lymphocyte populations with different sensitivity to cyclosporin have different plasma membrane potentials.
    Aszalos A; Damjanovich S; Colombani P; Hess A
    J Med; 1987; 18(5-6):351-74. PubMed ID: 3509802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 2 receptors on an insulin-specific T cell line: dynamics of receptor expression.
    Reske-Kunz AB; von Steldern D; Rüde E; Osawa H; Diamantstein T
    J Immunol; 1984 Sep; 133(3):1356-61. PubMed ID: 6205080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
    Beltz LA; Sztein MB; Kierszenbaum F
    J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocyte activation by OKT3: cyclosporine sensitivity and synergism with phorbol ester.
    Kay JE; Benzie CR
    Immunology; 1986 Feb; 57(2):195-9. PubMed ID: 3485075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen-dependent regulation of interleukin 2 receptor expression on cloned human cytotoxic T lymphocytes.
    Kaplan DR; Braciale VL; Braciale TJ
    J Immunol; 1984 Oct; 133(4):1966-9. PubMed ID: 6206143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.